- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: breast cancer positive for human epidermal growth factor receptor 2 (HER2) HER2 positive metastatic
Total 396108 results
-
GE HealthcareLaboratory Corporation of AmericaNot yet recruiting
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingHR Positive/HER2 Low Expression Metastatic Breast CancerChina
-
Olema Pharmaceuticals, Inc.Active, not recruitingHormone Receptor Positive Breast Carcinoma | HER2-negative Breast CancerUnited States, Australia
-
Janssen Research & Development, LLCCompletedPostmenopausal | Metastatic ER+ Her2- Breast CancerUnited States, France, Ukraine, United Kingdom, Belgium, Spain, Netherlands, Korea, Republic of, Russian Federation, Poland, Luxembourg, Ireland
-
Fudan UniversityRecruitingBreast Cancer | Breast Neoplasm | Breast Tumors | HER2-positive Breast Cancer | Locally Advanced Breast Cancer | HER2-negative Breast Cancer | Hormone Receptor Positive Tumor | Hormone Receptor Negative Tumor | Early-stage Breast Cancer | Triple-Negative Breast Cancer (TNBC)China
-
Pieris Pharmaceuticals, Inc.CompletedHER2-positive Breast Cancer | HER2-positive Gastric Cancer | HER2-positive Bladder Cancer | HER2-positive Solid TumorUnited States
-
Memorial Sloan Kettering Cancer CenterPuma Biotechnology, Inc.Active, not recruitingBreast CancerUnited States
-
M.D. Anderson Cancer CenterZymeworks BC Inc.Active, not recruitingBreast Cancer | HER2-positiveUnited States
-
Shengjing HospitalRecruiting
-
Sichuan Baili Pharmaceutical Co., Ltd.RecruitingHer2-positive/Low-expression Urinary and Digestive Tract TumorsChina
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingBreast Ductal Carcinoma In SituUnited States
-
University of NebraskaNational Cancer Institute (NCI)TerminatedStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | HER2-negative Breast CancerUnited States
-
Fudan UniversityGeneQuantum Healthcare (Suzhou) Co., Ltd.RecruitingAdvanced/ Metastatic Her-2 Positive Breast CancerChina
-
Hoffmann-La RocheCompleted
-
Guangdong Academy of Medical SciencesGuangzhou First People's Hospital; Guangzhou General Hospital of Guangzhou... and other collaboratorsUnknownHuman Epidermal Growth Factor 2 Negative Carcinoma of BreastChina
-
Filipa Lynce, MDAstraZeneca; Daiichi Sankyo, Inc.RecruitingBreast Cancer | HER2-positive Breast Cancer | Invasive Breast Cancer | Inflammatory Breast Cancer Stage III | HER2 Low Breast AdenocarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterUniversity of Pennsylvania; Genentech, Inc.CompletedBreast CancerUnited States
-
Medstar Health Research InstituteGenentech, Inc.TerminatedHER-2 Positive Metastatic Breast CancerUnited States
-
Ichnos Sciences SAGlenmark Pharmaceuticals S.A.TerminatedBreast CancerUnited States
-
Seagen Inc.Merck Sharp & Dohme LLCRecruitingHER2 Positive Breast CancerUnited States, Taiwan, Canada, Korea, Republic of, Austria, China, Spain, Japan, France, Italy, Switzerland, Australia, Belgium, Brazil, Germany, Portugal, United Kingdom, Netherlands, Czechia, Greece, Chile, Finland, Poland
-
Consorzio OncotechClinical Research Technology S.r.l.UnknownBreast Cancer | Metastatic Breast Cancer | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Locally Advanced Malignant NeoplasmItaly
-
The Methodist Hospital Research InstituteEli Lilly and CompanyRecruitingHER2-negative Breast Cancer | ER-Positive Breast CancerUnited States
-
AstraZenecaActive, not recruitingAdvanced ER-Positive HER2-Negative Breast CancerUnited States, Italy, Spain, Belgium, Poland, Canada, Germany, Korea, Republic of, Russian Federation, France, Israel, Hungary, Portugal, United Kingdom, Georgia, Ukraine
-
H. Lee Moffitt Cancer Center and Research InstituteNovartisCompletedBreast Cancer | Breast Cancer - Female | Breast Cancer - MaleUnited States
-
Bristol-Myers SquibbCompletedBreast CancerChina, Russian Federation, United States, Italy, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Colombia, Czechia, Denmark, Finland, France, Germany, Hong Kong, Ireland, Korea, Republic of, Mexico, Netherlands, Poland, Portuga... and more
-
Peking UniversityRecruiting
-
Beijing Mabworks Biotech Co., Ltd.RecruitingHER2-positive Recurrent or Metastatic Malignant Solid TumorChina
-
Asan Medical CenterCompletedMetastatic Breast CancerKorea, Republic of
-
M.D. Anderson Cancer CenterNot yet recruitingMetastatic Colorectal Cancer | KRAS G12C MutationsUnited States
-
Eisai Inc.CompletedLocally Recurrent | Metastatic Breast Cancer ( HER2 Negative)United States
-
Northwestern UniversityNational Cancer Institute (NCI); MedImmune LLC; Avon Breast Cancer FoundationCompletedStage IV Breast Cancer | Recurrent Breast Carcinoma | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu NegativeUnited States
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingHER2-expressing Advanced Solid TumorsChina
-
US Oncology ResearchMillennium Pharmaceuticals, Inc.Active, not recruitingBreast Cancer | Breast Tumors | Breast Carcinoma | Malignant Neoplasm of BreastUnited States
-
Sun Yat-sen UniversityUnknown
-
Fudan UniversityRecruitingLung Cancer, Non-small CellChina
-
United BioPharmaTri-Service General HospitalCompleted
-
City of Hope Medical CenterActive, not recruitingBreast Cancer | Stage IV Breast CancerUnited States
-
Shanghai Jiao Tong University School of MedicineJiangsu HengRui Medicine Co., Ltd.Active, not recruitingBreast Cancer InvasiveChina
-
Heidelberg Pharma AGU.S. Army Medical Research and Development CommandCompletedMetastatic Breast CancerUnited States, Belgium, Brazil, Germany, Israel
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingFirst-line Treatment | HER2-positive Metastatic Breast CancerChina
-
Artios Pharma LtdRecruitingAdvanced Solid Tumor | Metastatic Solid TumorUnited States
-
QuantumLeap Healthcare CollaborativeRecruitingBreast Cancer | Breast Neoplasms | Breast Tumors | HER2-positive Breast Cancer | Angiosarcoma | Locally Advanced Breast Cancer | HER2-negative Breast Cancer | TNBC - Triple-Negative Breast Cancer | Hormone Receptor Positive Tumor | Hormone Receptor Negative Tumor | Early-stage Breast CancerUnited States
-
Fudan UniversityCompleted
-
Technical University of MunichCompletedBreast Cancer | Gastric CancerGermany
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedHER2-positive Breast Cancer | Stage IV Breast Cancer | Recurrent Breast CancerUnited States
-
ETOP IBCSG Partners FoundationBreast International GroupCompletedPalbociclib in Molecularly Characterized ER-positive/HER2-negative Metastatic Breast Cancer (PYTHIA)Metastatic Breast CancerUnited Kingdom, Belgium, Italy
-
National Cancer Institute (NCI)TerminatedBreast Carcinoma | Stage IV Breast Cancer | Recurrent Breast CarcinomaUnited States
-
Seagen Inc.RemeGen Co., Ltd.RecruitingStomach Neoplasms | Breast Neoplasms | Triple Negative Breast Neoplasms | Gastroesophageal Junction Adenocarcinoma | HER2 Positive Breast Neoplasms | HER2 Low Breast NeoplasmsUnited States, Canada
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; GlaxoSmithKline; Brigham and Women's Hospital; North...CompletedBreast Cancer | Stage IV Breast CancerUnited States
-
Sichuan Baili Pharmaceutical Co., Ltd.Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.Not yet recruiting